Clinical Trial Update: Study to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia-negative B-precursor Acute Lymphoblastic Leukemia (B-ALL) [Phase 1]

View source ↗

Summary

This clinical trial update indicates completion of a Phase 1 study of intravenous blinatumomab in Japanese adults with newly diagnosed Philadelphia-negative B-p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• B-precursor Acute Lymphoblastic Leukemia

Drugs mentioned

• BLINCYTO (BLINATUMOMAB)

Snippet

Sponsor: Amgen | Conditions: B-precursor Acute Lymphoblastic Leukemia | Phase 1 | Status: COMPLETED